Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Scientist, New Target Interrogation, Cancer Biology/Immunology/Molecular Biology

Employer
Regeneron Pharmaceuticals, Inc.
Location
Tarrytown, New York
Start date
Jun 25, 2022

View more

Job Details

The New Target Interrogation group is looking for an outstanding scientist to join our team who focused on discovering innovative therapeutic hypothesis and novel biology in the field of solid and liquid cancers. The main focus of this role will be to design and execute experiments aimed at functionally validating genetic variants and at exploring their mechanism of action. The ideal candidate will be responsible of designing, execution and analysis of in vivo and in vitro experiments using a wide spectrum of established and innovative experimental techniques.

As a Scientist on the New Target Interrogation Group, a typical day might include:

  • Design, plan, and independently perform in vivo experiments by using mouse models to dissect sophisticated molecular phenotypes associated with human genetic findings in cancer and related disorders.

  • Implement novel technologies and experimental approaches in human cell-based systems, for molecular and characterization of new genetic variants associated to disease phenotypes.

  • Independently design and perform a variety of in vitro/ex vivo cell-based assays.

  • Perform flow cytometry analysis on human and murine cells and tissues.

  • Data analysis from RNASeq, scRNASeq and other omics using standard analysis packages available online.

  • Document procedures and results in a well-organized fashion; generate experimental reports.

  • Analyze results across experiments and projects, formulate therapeutic hypotheses and communicate findings and ideas via presentations in group and senior leader meetings.

  • Collaborate with cross-functional teams across the company to support the drug development pipeline.

This role might be for you if:

  • You enjoy and are passionate about bench science for drug discovery.

  • You possess excellent problem-solving abilities and are results driven.

  • You can excel in a fast-track environment while in charge of multiple projects.

To be considered for this role, you must have a PhD and 2+ years post doc or industry experience. We seek a candidate with a background in cellular and molecular biology, cancer biology, cancer genetics, cancer immunology or related field. Experience with cell culture (both primary cells and established cell lines), and a variety of in vitro/ex vivo cancer and immune cell-based assays is critical. Experience in omics data analysis is strongly preferred. Documented strong scientific record, excellent communication and presentation skills.

Does this sound like you? Apply now to take your first steps toward living the Regeneron Way! We have an inclusive and diverse culture that provides amazing benefits including health and wellness programs, fitness centers and stock for employees at all levels!

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or maternity status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. We will ensure that individuals with disabilities are provided reasonable accommodations to participate in the job application process. Please contact us to discuss any accommodations you think you may need.

Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
 
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Website
Phone
914-847-7000
Location
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert